Stem cell therapy; permitted in certain circumstances, notice and consent requirements provided, exceptions provided, State Board of Medical Examiners required to adopt rules

SB 299 allows Alabama-licensed doctors to offer certain stem cell therapies not approved by the FDA, provided they give patients written notice about the treatment's unapproved status, risks, and expected outcomes, and obtain written consent. The bill requires providers to display this notice prominently in their offices and include it in all advertisements for the therapy. It defines "stem cell therapy" to include afterbirth placental stem cells but explicitly excludes treatments using fetal or embryo cells from abortion. Violating these requirements is deemed unprofessional conduct by the State Board of Medical Examiners, which must adopt implementing rules by October 2025.